UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells

Oncoimmunology, 2024, Vol.13 (1), p.2318053-2318053

2024

Volltextzugriff (PDF)

The Universal Character of the Tumor-Associated Antigen Survivin

Clinical cancer research, 2007-10, Vol.13 (20), p.5991-5994

2007

Volltextzugriff (PDF)

The T-win® technology: immune-modulating vaccines

Seminars in immunopathology, 2019-01, Vol.41 (1), p.87-95

Andersen, Mads Hald

2019

Volltextzugriff (PDF)

Anti-cancer immunotherapy: breakthroughs and future strategies

Seminars in immunopathology, 2019-01, Vol.41 (1), p.1-3

Andersen, Mads Hald

2019

Volltextzugriff (PDF)

Increased myeloid‐derived suppressor cell activation in clonal cytopenia of undetermined significance and low‐risk myelodysplastic syndrome

British journal of haematology, 2024-09, Vol.205 (3), p.1220-1224

2024

Volltextzugriff (PDF)

The effect of short-chain fatty acids on human monocyte-derived dendritic cells

Scientific reports, 2015-11, Vol.5 (1), p.16148-16148, Article 16148

2015

Volltextzugriff (PDF)

Immune-suppressive properties of the tumor microenvironment

Cancer Immunology, Immunotherapy, 2013-07, Vol.62 (7), p.1137-1148

2013

Volltextzugriff (PDF)

Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells

Scientific reports, 2017-11, Vol.7 (1), p.14516-10, Article 14516

2017

Volltextzugriff (PDF)

Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms

Cancers, 2020-07, Vol.12 (7), p.1763

2020

Volltextzugriff (PDF)

The targeting of tumor-associated macrophages by vaccination

Cell Stress, 2019-04, Vol.3 (5), p.139-140

Andersen, Mads Hald

2019

Volltextzugriff (PDF)

The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated platelets

British journal of haematology, 2024-10, Vol.205 (4), p.1417-1429

2024

Volltextzugriff (PDF)

Cytotoxic T Cells

Journal of investigative dermatology, 2006-01, Vol.126 (1), p.32-41

2006

Volltextzugriff (PDF)

Healthy Donors Harbor Memory T Cell Responses to RAS Neo-Antigens

Cancers, 2020-10, Vol.12 (10), p.3045

2020

Volltextzugriff (PDF)

Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope

Cancer Immunology, Immunotherapy, 2019-11, Vol.68 (11), p.1901-1907

2019

Volltextzugriff (PDF)

Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial

Cancer Immunology, Immunotherapy, 2012-10, Vol.61 (10), p.1791-1804

2012

Volltextzugriff (PDF)

Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors – A phase I trial

Frontiers in immunology, 2022-10, Vol.13, p.1023023-1023023

2022

Volltextzugriff (PDF)

Durable Clinical Responses and Long-Term Follow-Up of Stage III-IV Non-Small-Cell Lung Cancer (NSCLC) Patients Treated With IDO Peptide Vaccine in a Phase I Study-A Brief Research Report

Frontiers in immunology, 2018-09, Vol.9, p.2145-2145

2018

Volltextzugriff (PDF)

HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients

Cancer research (Chicago, Ill.), 2013-03, Vol.73 (6), p.1764-1776

2013

Volltextzugriff (PDF)

CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment

Oncoimmunology, 2022-12, Vol.11 (1), p.2115655-2115655

2022

Volltextzugriff (PDF)

Tumor microenvironment antigens

Seminars in immunopathology, 2023-03, Vol.45 (2), p.253-264

Andersen, Mads Hald

2023

Volltextzugriff (PDF)

Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

Frontiers in immunology, 2024-07, Vol.15, p.1462081

2024

Volltextzugriff (PDF)

The expression, function and targeting of haem oxygenase-1 in cancer

Current cancer drug targets, 2014-01, Vol.14 (4), p.337-347

2014

Volltextzugriff (PDF)

Leveraging Endogenous Dendritic Cells to Enhance the Therapeutic Efficacy of Adoptive T-Cell Therapy and Checkpoint Blockade

Frontiers in immunology, 2020-09, Vol.11, p.578349-578349

2020

Volltextzugriff (PDF)

Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow

Frontiers in immunology, 2023-08, Vol.14, p.1240678-1240678

2023

Volltextzugriff (PDF)

Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab

Journal for immunotherapy of cancer, 2023-05, Vol.11 (5), p.e006755

2023

Volltextzugriff (PDF)

1 – 25 von 243

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(226)
Mit Volltextzugriff
(226)

Publikationsform

Sprache

Englisch
(240)
Dänisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(165)
Life Sciences & Biomedicine
(160)
Humans
(124)
Oncology
(98)
Immunology
(95)
Immunotherapy
(60)
Cancer
(51)
Lymphocytes
(43)
Neoplasms - Immunology
(37)
Biological And Medical Sciences
(33)
Medical Sciences
(33)
Melanoma
(33)
Vaccination
(32)
Antigens
(31)
Melanoma - Immunology
(31)
Tumors
(30)
Peptides
(29)
Antigens, Neoplasm - Immunology
(28)
Animals
(26)
T-Lymphocytes, Cytotoxic - Immunology
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells

The Universal Character of the Tumor-Associated Antigen Survivin

The T-win® technology: immune-modulating vaccines

Anti-cancer immunotherapy: breakthroughs and future strategies

Increased myeloid‐derived suppressor cell activation in clonal cytopenia of undetermined significance and low‐risk myelodysplastic syndrome

The effect of short-chain fatty acids on human monocyte-derived dendritic cells

Immune-suppressive properties of the tumor microenvironment

Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells

Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms

The targeting of tumor-associated macrophages by vaccination

The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated platelets

Cytotoxic T Cells

Healthy Donors Harbor Memory T Cell Responses to RAS Neo-Antigens

Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope

Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial

Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors – A phase I trial

Durable Clinical Responses and Long-Term Follow-Up of Stage III-IV Non-Small-Cell Lung Cancer (NSCLC) Patients Treated With IDO Peptide Vaccine in a Phase I Study-A Brief Research Report

HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients

CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment

Tumor microenvironment antigens

Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

The expression, function and targeting of haem oxygenase-1 in cancer

Leveraging Endogenous Dendritic Cells to Enhance the Therapeutic Efficacy of Adoptive T-Cell Therapy and Checkpoint Blockade

Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow

Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab

Suchergebnisse filtern